| |
Software Requirements
Microsoft Internet Explorer 5.01 or higher and Netscape Navigator 4.75 or higher are recommended. |
|
 |
J.Health Sci., 55(4), 516-524, 2009
Therapeutic Effects of Gyokuheifusan on NC/Nga Mouse Model of Allergic Dermatitis
Hiroko Nakatsukasa,*, a Fumitoshi Tago,a
Takuya Okamoto,b Mitsutoshi Tsukimoto,a
and Shuji Kojimaa
aDepartment of Radiation Biosciences, Faculty of Pharmaceutical Science, Tokyo University of Science (TUS), 2641 Yamazaki, Nodashi, Chiba 278-8510, Japan and
bIskra Industry Co., Ltd., 1-14-2 Nihonbashi, Chuo-ku 103-0027, Japan
Gyokuheifusan (GHS) is a traditional Chinese medicine (TCM) formula used to treat various allergic diseases; however, there is little information about its clinical efficacy or mechanism of action. We previously showed that GHS down-regulates over-production of IgE and interleukin (IL)-4 in a mouse model of ovalbumin (OVA)-induced asthma, a major Th2-dominant disease. Here, we investigated the effect of GHS in an NC/Nga mouse model of atopic dermatitis (AD) induced by mite antigen. NC/Nga mice were immunized with an intradermal injection of mite antigen extract twice a week from 6 to 12 weeks of age. GHS (3.0 g/kg) was orally administered daily to the GHS-treated group for 6 weeks, and dermatitis score and total serum IgE level were measured sequentially. Spleen was harvested at 13 weeks of age, and the levels of cytokines released from splenocytes (interferon (IFN)-γ, IL-4 and IL-5) and IgG1/IgG2a levels in sera were measured by ELISA. Mice treated with GHS showed milder dermatitis than the disease-control group and the increase of total serum IgE level tended to be suppressed by GHS. In addition, GHS treatment suppressed the production of IL-4 and IgG1, though it did not affect the production of IFN-γ and IgG2a; i.e., GHS normalized the Th1/Th2 balance. These results suggest that GHS inhibits the development and reduces the severity of AD, at least in this model.
|
|
